Vertex

Vertex Pharmaceuticals is a biotechnology company that develops and commercializes therapies for serious diseases, including cystic fibrosis and pain management.

Why it’s in the news: It is in the news due to its $10 billion acquisition of Crinetics Pharmaceuticals, a significant deal in the booming biotech M&A market.

Latest on Vertex

• Vertex Growth leads X Mile’s US$21.4M Series C for non-desk workforce AI
• STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx
• STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
• STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms
• Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion
• Google’s Vertex AI SDK could allow RCE through bucket squatting

Connections

3 entities linked to Vertex across the news graph.